Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5251
CALL
iQIYI
IQ
$1.3B
| $2.2M | ﹤0.01% |
523,500
-435,900
| -45% | -$1.75M |
|
5252
First Financial Corp
THFF
$976M
| $2.2M | ﹤0.01% |
49,410
-20,113
| -29% | -$880K |
|
|
TWKS
5253
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $2.2M | ﹤0.01% |
155,733
-31,873
| -17% | -$551K |
|
5254
PUT
Booz Allen Hamilton
BAH
$9.32B
| $2.2M | ﹤0.01% |
24,300
+3,800
| +19% | +$324K |
|
5255
CALL
Centrus Energy
LEU
$3.79B
| $2.19M | ﹤0.01% |
88,700
-57,100
| -39% | -$1.58M |
|
5256
PUT
Western Midstream Partners
WES
$20.2B
| $2.19M | ﹤0.01% |
90,300
+51,500
| +133% | +$1.32M |
|
5257
CALL
Dorman Products
DORM
$4.05B
| $2.19M | ﹤0.01% |
20,000
+2,600
| +15% | +$257K |
|
5258
PUT
Western Union
WU
$2.32B
| $2.19M | ﹤0.01% |
133,200
-8,700
| -6% | -$153K |
|
5259
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.3B
| $2.19M | ﹤0.01% |
34,375
+15,719
| +84% | +$1.1M |
|
5260
CRA International
CRAI
$1.06B
| $2.19M | ﹤0.01% |
24,516
+6,385
| +35% | +$536K |
|
|
AUY
5261
DELISTED
Yamana Gold, Inc.
AUY
| $2.19M | ﹤0.01% |
470,359
-5,085,901
| -92% | -$27.6M |
|
5262
iShares MSCI Ireland ETF
EIRL
$78.8M
| $2.19M | ﹤0.01% |
54,402
+15,140
| +39% | +$686K |
|
|
ITCI
5263
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.19M | ﹤0.01% |
38,300
+6,000
| +19% | +$340K |
|
5264
Innovator US Equity Accelerated 9 Buffer ETF July
XBJL
$75.7M
| $2.18M | ﹤0.01% |
88,454
+65,985
| +294% | +$1.69M |
|
|
ACB
5265
CALL
Aurora Cannabis
ACB
$233M
| $2.18M | ﹤0.01% |
165,350
+75,230
| +83% | +$1.88M |
|
5266
CALL
Meritage Homes
MTH
$4.76B
| $2.18M | ﹤0.01% |
60,200
-16,400
| -21% | -$655K |
|
|
IBTD
5267
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
| $2.18M | ﹤0.01% |
87,514
+48,286
| +123% | +$1.21M |
|
|
CEQP
5268
CALL
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.18M | ﹤0.01% |
90,600
-60,091
| -40% | -$1.73M |
|
5269
PUT
Fomento Económico Mexicano
FMX
$40.3B
| $2.18M | ﹤0.01% |
32,300
+14,000
| +77% | +$1.04M |
|
|
MNRL
5270
PUT
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $2.18M | ﹤0.01% |
88,500
+55,900
| +171% | +$1.54M |
|
5271
iShares National Muni Bond ETF
MUB
$45.8B
| $2.18M | ﹤0.01% |
20,486
-16,592
| -45% | -$1.77M |
|
5272
CALL
Array Technologies
ARRY
$778M
| $2.18M | ﹤0.01% |
197,800
-136,500
| -41% | -$1.35M |
|
5273
PUT
ProShares Ultra S&P500
SSO
$8.56B
| $2.18M | ﹤0.01% |
97,000
-62,600
| -39% | -$1.68M |
|
5274
Bank of Marin Bancorp
BMRC
$458M
| $2.18M | ﹤0.01% |
68,502
+7,438
| +12% | +$241K |
|
5275
CALL
Kyndryl
KD
$2.87B
| $2.18M | ﹤0.01% |
222,580
-55,640
| -20% | -$647K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.